RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+12.88%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.25B
AUM Growth
+$3.25B
(+10%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.75%
Holding
101
New
20
Increased
28
Reduced
23
Closed
18
Top Buys
| 1 |
Cigna
CI
|
$77.1M |
| 2 |
ALLK
Allakos
ALLK
|
$65.7M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
$63.1M |
| 4 |
Fate Therapeutics
FATE
|
$60.3M |
| 5 |
Tandem Diabetes Care
TNDM
|
$45.8M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$63.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$60.7M |
| 3 |
Labcorp
LH
|
$51.8M |
| 4 |
Insmed
INSM
|
$48.1M |
| 5 |
Centene
CNC
|
$41.4M |
Sector Composition
| 1 | Healthcare | 93.7% |
| 2 | Financials | 1.28% |
| 3 | Energy | 0.69% |
| 4 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NITE
26
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $42.5M | 1.31% | 2,080,846 +295,400 | +17% | +$6.04M |
|
27
Xeris Biopharma Holdings
XERS
$1.26B
| $42.4M | 1.3% | 2,412,640 -2 | -0% | -$35 |
|
28
eHealth
EHTH
$118M
| $41.6M | 1.28% | 1,472,595 +94,700 | +7% | +$2.68M |
|
|
HSKA
29
DELISTED
Heska Corp
HSKA
| $41M | 1.26% | 361,676 +6,900 | +2% | +$782K |
|
30
UnitedHealth
UNH
$281B
| $38.8M | 1.19% | 145,820 +2,800 | +2% | +$745K |
|
|
BLUE
31
DELISTED
bluebird bio
BLUE
| $36.8M | 1.13% | 252,100 -16,400 | -6% | -$2.39M |
|
|
OXFD
32
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $36.3M | 1.12% | 2,235,407 +200 | +0% | +$3.25K |
|
33
Replimune Group
REPL
$422M
| $35.3M | 1.09% | +2,192,957 | New | +$35.3M |
|
|
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
| $33.2M | 1.02% | 2,993,565 +35,800 | +1% | +$397K |
|
35
Penumbra
PEN
$10.6B
| $32.5M | 1% | 217,129 +144,959 | +201% | +$21.7M |
|
|
36
Centene
CNC
$14.3B
| $32.1M | 0.99% | 221,745 -286,240 | -56% | -$41.4M |
|
|
GRTS
37
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $31.9M | 0.98% | +2,242,636 | New | +$31.9M |
|
|
NUVA
38
DELISTED
NuVasive, Inc.
NUVA
| $31.2M | 0.96% | +439,700 | New | +$31.2M |
|
39
CVS Health
CVS
$92.8B
| $31M | 0.95% | +394,300 | New | +$31M |
|
|
CTLT
40
DELISTED
CATALENT, INC.
CTLT
| $30.5M | 0.94% | 668,850 +7,000 | +1% | +$319K |
|
|
CBIO
41
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $29.5M | 0.91% | 2,048,147 +18,800 | +0.9% | +$271K |
|
42
Teladoc Health
TDOC
$1.37B
| $28.9M | 0.89% | 334,700 +103,700 | +45% | +$8.95M |
|
43
ProQR Therapeutics
PRQR
$237M
| $28.1M | 0.86% | +1,450,925 | New | +$28.1M |
|
|
MOR
44
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $24M | 0.74% | 899,900 -369,900 | -29% | -$9.88M |
|
|
EPZM
45
DELISTED
Epizyme, Inc
EPZM
| $23.8M | 0.73% | 2,248,189 +226,800 | +11% | +$2.4M |
|
46
Zoetis
ZTS
$69.3B
| $23.2M | 0.71% | 253,300 +4,200 | +2% | +$385K |
|
|
LHCG
47
DELISTED
LHC Group LLC
LHCG
| $22.4M | 0.69% | +217,480 | New | +$22.4M |
|
|
SYNH
48
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22.1M | 0.68% | 428,473 -553,200 | -56% | -$28.5M |
|
|
PRAH
49
DELISTED
PRA Health Sciences, Inc.
PRAH
| $22M | 0.68% | +200,000 | New | +$22M |
|
50
Agilent Technologies
A
$35.7B
| $21.6M | 0.66% | +306,400 | New | +$21.6M |
|